doconexent Delayed Release Oral Capsule

Category(s)
prescription
SPL Type(s)
Human Prescription
Master SPL
Pronova Corp (2014-09-15)
Oldest Current Product
2014-08-28
License(s)
UNAPPROVED DRUG OTHER MARKETING CATEGORY
RxNORM
DELAYED RELEASE ORAL CAPSULE\DOCONEXENT

product(s) by strength(s)

doconexent 350 mg delayed release oral capsule

product(s)(s)

#idcategorylabelerfirst marketedactive ingredient(s)dose formspl
1675550153UNAPPROVED DRUG OTHER MARKETING CATEGORYPronova Corp2014-08-28.ALPHA.-TOCOPHEROL ACETATE, D-, .BETA.-CAROTENE, ASCORBIC ACID, CHOLECALCIFEROL, CYANOCOBALAMIN, DOCONEXENT, DOCUSATE SODIUM, FERROUS BISGLYCINATE, FOLIC ACID, MAGNESIUM OXIDE, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, RIBOFLAVIN, SELENIUM, THIAMINE HYDROCHLORIDE, ZINC GLYCINATEKIT19df5244-1a40-4f9e-af28-e2a90d996566

spl(s)

#idtitlecategorytypelabelerlast updateversionproduct(s)
119df5244-1a40-4f9e-af28-e2a90d996566 (view SPL)prescriptionHuman PrescriptionPronova Corp2014-09-151675550153

Data from: LOINC, MTHSPL, NDFRT, NCIT, RxNORM, UNII